Loading…

Dna sequence and conformation specificity of lupus autoantibodies. preferential binding to the left‐handed z‐dna form of synthetic polynucleotides

The binding specificity of 16 sera from systemic lupus erythematosus (SLE) patients was studied by enzyme‐linked immunosorbent assay (ELISA), using 4 native DNAs of different guanine‐cytosine (G‐C) content and a group of synthetic polynucleotides. All the SLE sera showed increased binding to poly(dA...

Full description

Saved in:
Bibliographic Details
Published in:Arthritis and rheumatism 1988-03, Vol.31 (3), p.367-377
Main Authors: Thomas, T. J., Meryhew, Nancy L., Messner, Ronald P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The binding specificity of 16 sera from systemic lupus erythematosus (SLE) patients was studied by enzyme‐linked immunosorbent assay (ELISA), using 4 native DNAs of different guanine‐cytosine (G‐C) content and a group of synthetic polynucleotides. All the SLE sera showed increased binding to poly(dA‐dC)‐poly(dG‐dT), compared with calf thymus DNA in the right‐handed B conformation. No significant differences were noted in binding of selected SLE sera to the native DNAs that differed in G‐C content or superhelicity of DNA. With poly(dG‐dC).poly(dG‐dC) and poly(dG‐m5dC).poly(dG‐m5dC), the majority of SLE sera showed a preferential binding to the salt‐induced Z form, compared with the B form. In addition, an average twelve‐fold increase was found in binding to Z‐form brominated poly(dG‐dC).poly(dG‐dC) compared with B‐form poly(dG‐dC).poly(dG‐dC), when the polymers were coated on the plates in 0.15M NaCl. The preferential binding of SLE sera to poly(dA‐dC).poly(dG‐dT) and to Z‐DNA may be important in the formation of circulating immune complexes and subsequent vascular damage, or may provide a clue to the mechanism of production of anti‐DNA antibodies in this disease.
ISSN:0004-3591
1529-0131
DOI:10.1002/art.1780310308